ALVR
$7.39
Allovir
($.13)
(1.73%)
ALVR
Earnings Whisper ®
N/A
3rd Quarter September 2022
Consensus:  ($0.52)
Revenue:  N/A
Thursday
Nov 3
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, August 04, 2022

What do you expect when ALVR reports earnings?
Beat
Meet
Miss

Where is ALVR's stock price going from here?
Up
Flat
Down
Stock chart of ALVR
Analysts
Summary of analysts' recommendations for ALVR
Score
Grade
Pivots
Resistance
$8.21
$7.91
$7.65

$7.35

Support
$7.09
$6.79
$6.53
Tweet
Growth
Description
AlloVir, Inc. is a late clinical-stage cell therapy company which focus on restoring natural immunity against life-threatening viral diseases. AlloVir, Inc. is based in CAMBRIDGE, Mass.